Collectively, CYTOR attenuated CH possibly attributed to the regulation of the miR-155–IKKi axis and NF-kB signaling pathway, indicating CYTOR as an effective regulator for CH. The gene discussed is NFKB1; the disease is cyclic hematopoiesis.